On 2024-05-14, Reviva Pharmaceuticals Holdings, Inc. (RVPH) announced earnings per share of $-0.25 for the fiscal quarter ending 2024-03-31, beating the average analyst estimate of $-0.28.
The next expected annoucement date for quarterly earnings is 2024-08-12, with an average estimated earnings per share of $-0.28 for the fiscal quarter ending 2024-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2024-05-14 | 2024-03-31 | $-0.28 | $-0.25 |
| 2024-04-15 | 2023-12-31 | -- | $-0.35 |
| 2023-11-14 | 2023-09-30 | $-0.35 | $-0.44 |
| 2023-08-14 | 2023-06-30 | $-0.29 | $-0.55 |
| 2023-05-15 | 2023-03-31 | $-0.36 | $-0.30 |
| 2023-03-30 | 2022-12-31 | $-0.23 | $-0.38 |
| 2022-11-14 | 2022-09-30 | $-0.30 | $-0.18 |
| 2022-08-15 | 2022-06-30 | $-0.31 | $-0.29 |
| 2022-05-16 | 2022-03-31 | $-0.28 | $-0.40 |
| 2022-03-15 | 2021-12-31 | $-0.24 | $-0.24 |
| 2021-11-15 | 2021-09-30 | $-0.25 | $-0.12 |
| 2021-08-16 | 2021-06-30 | $-0.24 | $-0.12 |
| 2021-05-17 | 2021-03-31 | -- | $-0.10 |
| 2021-03-22 | 2020-12-31 | -- | $-0.84 |
| 2021-01-14 | 2020-11-30 | -- | $-0.13 |
| 2020-10-14 | 2020-08-31 | -- | $-0.19 |
| 2020-07-07 | 2020-05-31 | -- | $-0.09 |
| 2020-05-04 | 2020-02-29 | -- | $-0.13 |
| 2020-01-10 | 2019-11-30 | -- | $-0.05 |
| 2019-10-08 | 2019-08-31 | -- | $-0.02 |
| 2019-07-03 | 2019-05-31 | -- | $-0.01 |